Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 19 Apr 2024

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer

in Cancer Immunity and Immunotherapy

Ting Gao
Baohong Jiang
Yu Zhou
Rongfang He
Liming Xie
Yuehua Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369892

3,620 views
3 citations

Original Research

Published on 19 Apr 2024

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

in Cancer Immunity and Immunotherapy

Heleen Hanssens
Fien Meeus
Yannick De Vlaeminck
Quentin Lecocq
Janik Puttemans
Pieterjan Debie
Timo W. M. De Groof
Cleo Goyvaerts
Kim De Veirman
Karine Breckpot

Frontiers in Immunology

doi 10.3389/fimmu.2024.1389018

4,016 views

Original Research

Published on 18 Apr 2024

Predicting effect of anti-PD-1/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS

in Cancer Immunity and Immunotherapy

Botong Liu
Jinyu Shi
Rui Su
Ran Zheng
Fan Xing
Yuan Zhang
Nanya Wang
Huanwen Chen
Shouhua Feng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1370771

2,000 views

Original Research

Published on 18 Apr 2024

Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression

in Cancer Immunity and Immunotherapy

Nayoung Kim
Eunbi Yi
Eunbi Lee
Hyo Jin Park
Hun Sik Kim

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388018

5,753 views
7 citations

Original Research

Published on 18 Apr 2024

The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors

in Cancer Immunity and Immunotherapy

Wei Sun
Xue Yin
Xiaomin Liu
Jianying Wei
Minghua Yu
Wendong Li
Xiaoyan Ding
Jinglong Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380477

2,545 views
4 citations

Original Research

Published on 18 Apr 2024

Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer

in Cancer Immunity and Immunotherapy

Ze Yuan
Binbin Li
Wenmin Liao
Da Kang
Xinpei Deng
Hailin Tang
Jindong Xie
Dandan Hu
Aiqin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382520

4,781 views
12 citations

Original Research

Published on 18 Apr 2024

Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

in Cancer Immunity and Immunotherapy

Vikram Adhikarla
Dennis Awuah
Enrico Caserta
Megan Minnix
Maxim Kuznetsov
Amrita Krishnan
Jefferey Y. C. Wong
John E. Shively
Xiuli Wang
Flavia Pichiorri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1358478

3,431 views
8 citations

Original Research

Published on 18 Apr 2024

MLXIPL associated with tumor-infiltrating CD8+ T cells is involved in poor prostate cancer prognosis

in Cancer Immunity and Immunotherapy

Yuanming Fan
Yuqiu Ge
Kaiming Niu
Ying Li
Lian-Wen Qi
Haixia Zhu
Gaoxiang Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1364329

2,126 views
3 citations

Original Research

Published on 18 Apr 2024

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

in Cancer Immunity and Immunotherapy

Hélène Lê
Jules Deforges
Pasquale Cutolo
Anissa Lamarque
Guoqiang Hua
Véronique Lindner
Shreyansh Jain
Jean-Marc Balloul
Nadia Benkirane-Jessel
Eric Quéméneur

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379613

3,995 views
3 citations

Original Research

Published on 18 Apr 2024

Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Jie Lou
Bingxin Gong
Yi Li
Yusheng Guo
Lin Li
Jing Wang
Weiwei Liu
Ziang You
Hongyong Zhang
Feng Pan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1332303

2,923 views
2 citations

Editorial

Published on 18 Apr 2024

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance

in Cancer Immunity and Immunotherapy

Marta Barisa
Daniel Abate-Daga
Jonathan Fisher

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414812

1,607 views

General Commentary

Published on 18 Apr 2024

Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma

in Cancer Immunity and Immunotherapy

Zhongling Sun
Ran Tan
Huanling Wu
Xiaosheng Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377221

1,380 views

Review

Published on 17 Apr 2024

A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance

in Cancer Immunity and Immunotherapy

Meng-Yao Xu
Zhi-Yu Xia
Jian-Xuan Sun
Chen-Qian Liu
Ye An
Jin-Zhou Xu
Si-Han Zhang
Xing-Yu Zhong
Na Zeng
Si-Yang Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395047

4,426 views
5 citations

Correction

Published on 17 Apr 2024

Corrigendum: Therapeutic strategies targeting folate receptor α for ovarian cancer

in Cancer Immunity and Immunotherapy

Jia Mai
Limei Wu
Ling Yang
Ting Sun
Xiaojuan Liu
Rutie Yin
Yongmei Jiang
Jinke Li
Qintong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403324

1,430 views

Review

Published on 17 Apr 2024

Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review

in Cancer Immunity and Immunotherapy

Chinmayee Priyadarsini Dash
Dhruba Sonowal
Prachi Dhaka
Rohit Yadav
Dewan Chettri
Bibhu Prasad Satapathy
Pooja Sheoran
Vivek Uttam
Manju Jain
Aklank Jain

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390498

4,347 views
5 citations

Original Research

Published on 17 Apr 2024

Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation

in Cancer Immunity and Immunotherapy

Yongkui Yin
Xiaojie Yang
Zhengyi Cheng
Hui Wang
Jun Lei
Dan Wang
Peiwen Wang
Biao Li
Jing Mi
Qi Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371584

3,389 views
4 citations